The Acceptability of a Real-Time Medication Monitoring-Based Digital Adherence Tool Among Young People Living with HIV in Malawi
AIDS and Behavior · 2026
DOI: 10.1007/s10461-025-04885-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift AIDS and Behavior, 2026. Verfasst von Takondwa Charles Msosa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Department of Global Health, location University of Amsterdam, Amsterdam, The Netherlands. takondwamsosa@outlook.com. Hauptthemen laut MEDLINE: HIV Infections, Reminder Systems, Medication Adherence, Anti-HIV Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership, Helse Nord RHF.
Abstract (Originalsprache)
Adherence to antiretroviral therapy (ART) is required for young people living with HIV (YPLHIV, 15-24 years) to achieve viral suppression, prevent transmission, and reduce HIV-related morbidity and mortality. Real time medication monitoring based digital adherence tools (RTMM-DATs) - a combination of RTMMs (smart pillboxes), customised adherence feedback, SMS reminders, and optional alarms - may be used to provide promising interventions to improve ART adherence and viral suppression in YPLHIV. In this study, we sought to investigate the concurrent acceptability of a RTMM-DAT intervention which included RTMMs, customised adherence feedback, SMS reminders, and optional alarms, in non-adherent YPLHIV on ART in Malawi enrolled in a randomised controlled trial (RCT) to investigate the effect of the intervention on ART adherence and viral suppression. As a secondary objective, we explored barriers to ART adherence in YPLHIV using the intervention. We conducted a phenomenological study in fourteen YPLHIV enrolled in the intervention arm of the RCT for at least six months using semi-structured interviews between June and July 2024. The interview guide was structured around the constructs of the Theoretical Framework of Acceptability (TFA). Inductive and deductive thematic analysis were performed to achieve the objectives. Overall, the participants expressed positive attitudes toward the intervention and appreciated the portable and discreet design of the RTMM. They appreciated the intervention's usefulness in addressing forgetfulness and promoting routine medication use. Neutral SMS reminders and tailored adherence feedback were appreciated for promoting adherence while safeguarding privacy. Challenges included device recharging in settings with limited electricity, reliance on mobile phones for SMS reminders, lack of remote user access to adherence reports, potential unintended disclosure from audible alarms, and users’ underlying social insecurities due to stigma. Furthermore, participants continued to face multiple and complex challenges to ART adherence, such as food insecurity, drug side effects, forgetfulness, and social stigma before and after engaging with the intervention. In conclusion, the intervention was generally acceptable among YPLHIV in Malawi. Addressing barriers such as electricity access, stigma, and enhancing user customisability and access to adherence reports could improve the intervention’s acceptability. Additionally, tailoring the intervention to the socio-cultural context of YPLHIV is essential to improve acceptability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam UMC, Department of Global Health, location University of Amsterdam, Amsterdam, The Netherlands. takondwamsosa@outlook.com.
- Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands. takondwamsosa@outlook.com.
- Helse Nord Tuberculosis Initiative, Department of Pathology, Kamuzu University of Health Sciences, Blantyre, Malawi. takondwamsosa@outlook.com.
- Helse Nord Tuberculosis Initiative, Department of Pathology, Kamuzu University of Health Sciences, Blantyre, Malawi.
- Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
- Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Förderung
- European and Developing Countries Clinical Trials Partnership
- Helse Nord RHF
Zitieren
APA
Msosa, T. C., Phuka, F., Sumari-de Boer, M., Mhango, O., Twabi, H. H., Mukoka, M., Swai, I., Aarnoutse, R., de Wit, T. F. R., Ngowi, K., Lunda, E., Mphande, W., Msefula, C., & Nliwasa, M. (2026). The Acceptability of a Real-Time Medication Monitoring-Based Digital Adherence Tool Among Young People Living with HIV in Malawi. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04885-7
Vancouver
Msosa TC, Phuka F, Sumari-de Boer M, Mhango O, Twabi HH, Mukoka M, et al. The Acceptability of a Real-Time Medication Monitoring-Based Digital Adherence Tool Among Young People Living with HIV in Malawi. AIDS and Behavior. 2026. doi:10.1007/s10461-025-04885-7
BibTeX
@article{Msosa2026,
author = {Msosa, Takondwa Charles and Phuka, Felix and Sumari-de Boer, Marion and Mhango, Owen and Twabi, Hussein Hassan and Mukoka, Madalo and Swai, Iraseni and Aarnoutse, Rob and de Wit, Tobias F Rinke and Ngowi, Kennedy and Lunda, Edred and Mphande, Wongani and Msefula, Chisomo and Nliwasa, Marriott},
title = {The Acceptability of a Real-Time Medication Monitoring-Based Digital Adherence Tool Among Young People Living with HIV in Malawi},
journal = {AIDS and Behavior},
year = {2026},
doi = {10.1007/s10461-025-04885-7}
}
EUVIMED